BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 14, 2003
View Archived Issues
PPARdelta shown to inhibit cardiac inflammatory responses in vitro and in vivo
Read More
Antiproliferative and differentiation-inducing effects of ratjadone on coronary smooth muscle cells
Read More
Antithrombotic efficacy of the PAR-1 antagonist E-5555 in guinea pigs
Read More
VX-702, a p38 MAPK inhibitor, reduces myocardial ischemia-reperfusion damage in rats
Read More
Amersham inlicenses amyloid-targeting PET agents
Read More
New uroselective alpha1-AR antagonists developed at Ranbaxy
Read More
Esteve scientists claim new NPY Y5 modulators for obesity and other uses
Read More
Pfizer presents two series of PPAR modulators with potential as antidiabetic agents
Read More
Novel estrogen receptor modulators prepared and tested by Wyeth researchers
Read More
CyFi patent covers sodium channel blockers as mucosa protecting agents
Read More
Lilly presents new factor Xa inhibitors
Read More
Orchid scientists present new COX-2/COX-3 inhibitors
Read More
New 5-HT1F agonists and their use in migraine therapy reported by Lilly
Read More
MRA potentially effective for adult rheumatoid arthritis
Read More
ICN becomes Valeant Pharmaceuticals International
Read More
Two additional pivotal trials for IGN-101
Read More
MK-0869 phase III program discontinued
Read More
New safety trial for HCV drug R-803
Read More
Preliminary phase Ib results support antiretroviral activity of TNX-355 for HIV
Read More
AIDSVAX B/E fails to meet endpoints in phase III HIV trial
Read More
Nitrate ester from GBTherapeutics improves cognition in rat model
Read More
YM BioSciences and Oncoscience sign licensing agreement for TheraCIM hR3
Read More
Erythropoietin and analogue AA-18231 afford significant neuroprotection in hypoxia-ischemia
Read More
Inhibition of glutamate carboxypeptidase II as a novel approach to diabetic retinopathy
Read More
Neuroprotective and antiinflammatory effects established for GLI-7501
Read More
Potent, rapid-acting antidepressant emerges from major Lundbeck program
Read More
Human central nervous system stem cell grafts improve recovery in SCI model
Read More
Human embryonic stem cell-derived oligodendrocyte progenitors: a promising approach to SCI
Read More